Nephris
nephris.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Nephris. Ricerca e innovazioneper la malattia renale diabetica ; La nostra missione La missione di Nephris è di sviluppare terapie innovative first-in-classper la malattia renale cronica nei pazienti diabetici.
News
Nephris Welcomes Discovery of Novel Pathogenic Factor in Diabetic Kidney Disease
Nephris, a biotech company developing first-in-class therapies for chronic kidney diseases, extends its congratulations to the researchers from the Romeo and Enrica Invernizzi Pediatric Clinical Research Center of the University of Milan who participated,
Read more
Report
Sofinnova Partners: Nephris Welcomes Discovery of Novel Pathogenic Factor in Diabetic Kidney Disease
MILAN, ITALY / ACCESSWIRE / August 10, 2022 / Nephris, a biotech company developing first-in-class therapies for chronic kidney diseases, extends its congratulations to the researchers from the Romeo and
Read more
Report
Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases
Milan-Based Nephris Has Raised €3 Million in Seed Financing To Explore New Therapies for Diabetic Nephropathy, a Complication of Type 1 and Type 2 DiabetesMILAN, ITALY / ACCESSWIRE / April 20, 2022 / Sofinnova Partners, a leading European life sciences ve
Read more
Report
Report
Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases
Milan-Based Nephris Has Raised €3 Million in Seed Financing To Explore New Therapies for Diabetic Nephropathy, a Complication of Type 1 and Type 2 DiabetesMILAN, ITALY / ACCESSWIRE / April 20, 2022 / Sofinnova
Read more
Report